Gene and protein expression of RCAS1 in hepatocellular carcinoma

Masahide Ikeguchi1, Yasuaki Hirooka, Nobuaki Kaibara

  • 1Division of Operating Room, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago 683-8504, Japan. masaike@grape.med.tottori-u.ac.jp

Anticancer Research
|February 26, 2004
PubMed
Abstract

Insights

Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) protein levels in primary hepatocellular carcinoma (HCC) tumors predict transcatheter arterial embolization (TAE) effectiveness. High RCAS1 expression indicates better survival after TAE for new tumor development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hepatobiliary Surgery

Background:

  • Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is a tumor-associated antigen expressed on hepatocellular carcinoma (HCC) cell membranes.
  • RCAS1 expression can induce apoptosis in tumor-infiltrating lymphocytes, potentially impacting anti-tumor immunity.
  • The clinical significance of RCAS1 in HCC, particularly its correlation with treatment outcomes, requires further investigation.

Purpose of the Study:

  • To analyze the clinical importance of RCAS1 gene and protein expression in surgically resected HCC.
  • To evaluate the correlation between RCAS1 expression levels and patient survival, especially after transcatheter arterial embolization (TAE) for recurrent tumors.
  • To determine if RCAS1 expression can serve as a prognostic marker for HCC patients undergoing TAE.

Main Methods:

  • RCAS1 gene and protein expression were quantified in 60 HCC patients using real-time RT-PCR and immunohistochemistry.
  • Expression levels were correlated with clinicopathological features, including tumor differentiation, progression, and disease-free survival.
  • Survival analysis was performed for patients who developed new tumors and received TAE, stratifying by RCAS1 expression levels.

Main Results:

  • RCAS1 mRNA and protein expression levels showed a significant positive correlation.
  • RCAS1 protein was detected in 75% of HCC cases, with high immunoreactivity in 31.7%.
  • High RCAS1 protein expression in primary tumors was associated with significantly longer survival (41.4 months) after TAE compared to low expression (23.5 months) in patients with new tumor development (p = 0.024).

Conclusions:

  • RCAS1 protein expression in primary HCC tumors is not correlated with tumor differentiation or progression.
  • Low RCAS1 protein expression in primary tumors is an independent poor prognostic factor for patients who develop new tumors after initial resection.
  • RCAS1 protein expression may serve as a valuable predictive marker for the effectiveness of TAE treatment in HCC patients with recurrent disease.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...